Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...
Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
What if clinicians could predict the success of any cancer treatment, ensuring each patient receives the most effective care? The challenge lies in the diverse nature of the disease. There are ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
News-Medical.Net on MSN
Combination therapy offers hope for AML patients facing drug resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...
Once a medical miracle, antibiotics are now losing their power. Across the world, common infections are becoming harder—and ...
The U.N. health agency found that one in six infections worldwide was resistant to the most commonly available antibiotics. By Andrew Jacobs Across the world, the spread of dangerous infections that ...
Researchers analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. Researchers at University of California San Diego ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results